Medicine and Dentistry
Patient
100%
Ledipasvir Plus Sofosbuvir
80%
Ribavirin
50%
Genotype
50%
Therapeutic Procedure
40%
Liver Cirrhosis
30%
Infection
20%
Vedroprevir
20%
Combination Therapy
10%
Adverse Event
10%
Treatment Duration
10%
Nucleotide
10%
Acute Heart Infarction
10%
Cardiomyopathy
10%
Enalapril Maleate
10%
Hepacivirin Inhibitor
10%
Laboratory
10%
Arm
10%
Mechanism of Action
10%
Male
10%
Hispanic
10%
Pharmacology, Toxicology and Pharmaceutical Science
Ledipasvir Plus Sofosbuvir
80%
Ribavirin
50%
Liver Cirrhosis
30%
Infection
20%
Vedroprevir
20%
Adverse Event
10%
Acute Heart Infarction
10%
Enalapril Maleate
10%
Cardiomyopathy
10%
Hepacivirin Inhibitor
10%
Neuroscience
Ledipasvir Plus Sofosbuvir
80%
Ribavirin
50%
Cardiomyopathy
10%
Myocardial Infarction
10%
Protease Inhibitor
10%
Hepacivirin
10%
NS5B
10%
Immunology and Microbiology
Genotype
50%
Ribavirin
50%
NS5B
10%
Arm
10%
Biochemistry, Genetics and Molecular Biology